Biotechnology in the United Kingdom

Biotechnology in the United Kingdom industry profile provides top-line qualitative and quantitative summary information including: market size (value 2014-18, and forecast to 2023). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

– The biotechnology industry consists of the development, manufacturing, and industrying of products based on advanced biotechnology research.

– The UK biotechnology industry had total revenues of $11.0bn in 2018, representing a compound annual growth rate (CAGR) of 8% between 2014 and 2018.

– The medical/healthcare segment was the industry's most lucrative in 2018, with total revenues of $7.3bn, equivalent to 66% of the industry's overall value.

– The UK’s industry is mainly driven by biotechnology related to healthcare, segments that are boosted by the talented pool of scientists in the country.

Scope

– Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in the United Kingdom

– Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in the United Kingdom

– Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance

– Add weight to presentations and pitches by understanding the future growth prospects of the United Kingdom biotechnology market with five year forecasts

Reasons to buy

- What was the size of the United Kingdom biotechnology market by value in 2018?

- What will be the size of the United Kingdom biotechnology market in 2023?

- What factors are affecting the strength of competition in the United Kingdom biotechnology market?

- How has the market performed over the last five years?

- What are the main segments that make up the United Kingdom's biotechnology market?

Companies mentioned

AstraZeneca PLC

Novartis AG

GE Healthcare

Sanofi SA

Table of Contents

Table of Contents

1 Executive Summary

1.1. Market value

1.2. Market value forecast

1.3. Category segmentation

1.4. Geography segmentation

1.5. Market rivalry

1.6. Competitive Landscape

2 Market Overview

2.1. Market definition

2.2. Market analysis

3 Market Data

3.1. Market value

4 Market Segmentation

4.1. Category segmentation

4.2. Geography segmentation

5 Market Outlook

5.1. Market value forecast

6 Five Forces Analysis

6.1. Summary

6.2. Buyer power

6.3. Supplier power

6.4. New entrants

6.5. Threat of substitutes

6.6. Degree of rivalry

7 Competitive Landscape

7.1. Who are the leading players in the market?

7.2. What strategies do leading players follow?

7.3. What are the strengths of leading players?

7.4. Have there been any product approvals in recent years?

7.5. What has been the rationale behind recent M&A activity?

8 Company Profiles

8.1. AstraZeneca PLC

8.2. Novartis AG

8.3. GE Healthcare

8.4. Sanofi SA

9 Macroeconomic Indicators

9.1. Country data

10 Appendix

10.1. Methodology

10.2. Industry associations

10.3. Related MarketLine research

10.4. About MarketLine

List of Tables

List of Tables

Table 1: United Kingdom biotechnology industry value: $ million, 2014-18

Table 2: United Kingdom biotechnology industry category segmentation: $ million, 2018

Table 3: United Kingdom biotechnology industry geography segmentation: $ million, 2018

Table 4: United Kingdom biotechnology industry value forecast: $ million, 2018-23

Table 5: AstraZeneca PLC: key facts

Table 6: AstraZeneca PLC: Annual Financial Ratios

Table 7: AstraZeneca PLC: Key Employees

Table 8: Novartis AG: key facts

Table 9: Novartis AG: Annual Financial Ratios

Table 10: Novartis AG: Key Employees

Table 11: Novartis AG: Key Employees Continued

Table 12: GE Healthcare: key facts

Table 13: GE Healthcare: Key Employees

Table 14: GE Healthcare: Key Employees Continued

Table 15: Sanofi SA: key facts

Table 16: Sanofi SA: Annual Financial Ratios

Table 17: Sanofi SA: Key Employees

Table 18: Sanofi SA: Key Employees Continued

Table 19: United Kingdom size of population (million), 2014-18

Table 20: United Kingdom gdp (constant 2005 prices, $ billion), 2014-18

Table 21: United Kingdom gdp (current prices, $ billion), 2014-18

Table 22: United Kingdom inflation, 2014-18

Table 23: United Kingdom consumer price index (absolute), 2014-18

Table 24: United Kingdom exchange rate, 2014-18

List of Figures

List of Figures

Figure 1: United Kingdom biotechnology industry value: $ million, 2014-18

Figure 2: United Kingdom biotechnology industry category segmentation: % share, by value, 2018

Figure 3: United Kingdom biotechnology industry geography segmentation: % share, by value, 2018

Figure 4: United Kingdom biotechnology industry value forecast: $ million, 2018-23

Figure 5: Forces driving competition in the biotechnology industry in the United Kingdom, 2018

Figure 6: Drivers of buyer power in the biotechnology industry in the United Kingdom, 2018

Figure 7: Drivers of supplier power in the biotechnology industry in the United Kingdom, 2018

Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in the United Kingdom, 2018

Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in the United Kingdom, 2018

Figure 10: Drivers of degree of rivalry in the biotechnology industry in the United Kingdom, 2018

    Pricing

Discounts available for multiple report purchases.

reportstore@marketline.com
+44 (0) 161 359 5817

Saved reports